The REPAIR Impact Fund: Reflections from the first year Access Viewpoint here: The REPAIR Impact Fund: Reflections from the first year – by Aleks Engel Author: Aleks Engel Tags: Antimicrobial Viewpoint article, Phase 1, Preclinical development, WHO priority pathogens
